HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Hayashi Selected Research

efonidipine

11/2010Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.
11/2005Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
7/2003Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
2/2003Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Hayashi Research Topics

Disease

13Hypertension (High Blood Pressure)
01/2021 - 02/2003
11Chronic Renal Insufficiency
10/2015 - 07/2003
10Proteinuria
10/2015 - 02/2003
6Fibrosis (Cirrhosis)
01/2014 - 12/2005
6Hypersensitivity (Allergy)
04/2013 - 06/2009
5Neoplasms (Cancer)
07/2016 - 07/2006
5Insulin Resistance
03/2016 - 12/2002
5Diabetic Nephropathies (Diabetic Nephropathy)
01/2016 - 01/2003
5Spinal Cord Injuries (Spinal Cord Injury)
02/2014 - 12/2011
4Acute Kidney Injury (Acute Renal Failure)
12/2021 - 10/2005
4Inflammation (Inflammations)
03/2016 - 01/2010
4Renal Insufficiency (Renal Failure)
03/2016 - 11/2013
4Ischemia
12/2005 - 05/2002
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2003
3Dysmenorrhea (Menstrual Pain)
04/2020 - 01/2020
3Atrophy
03/2016 - 10/2002
3Albuminuria
01/2016 - 11/2013
3Chronic Kidney Failure (Chronic Renal Failure)
10/2015 - 02/2005
3Kidney Diseases (Kidney Disease)
10/2015 - 12/2005
3Lung Injury
07/2011 - 01/2010
3Vascular System Injuries
07/2007 - 12/2003
2Stroke (Strokes)
01/2020 - 10/2014
2Hemolytic Anemia
01/2016 - 11/2013
2Thrombocytopenia (Thrombopenia)
01/2016 - 11/2013
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2015 - 01/2011
2Interstitial Nephritis (Tubulointerstitial Nephritis)
11/2015 - 10/2010
2Melanoma (Melanoma, Malignant)
02/2014 - 01/2014
2Infections
11/2013 - 06/2006
2Autoimmune Diseases (Autoimmune Disease)
04/2013 - 03/2010
2Neutropenia
12/2012 - 08/2012
2Spinal Cord Diseases
08/2012 - 03/2012
2Pneumonia (Pneumonitis)
11/2010 - 06/2009
2Pheochromocytoma
07/2010 - 07/2006
2Edema (Dropsy)
05/2008 - 01/2007
2Atherosclerosis
07/2006 - 12/2005
2Ureteral Obstruction
01/2006 - 12/2005
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2005 - 09/2004
2Renal Artery Obstruction (Renal Artery Stenosis)
07/2002 - 05/2002
1Critical Illness (Critically Ill)
12/2021
1Pain (Aches)
01/2020
1Dermatomyositis (Dermatopolymyositis)
01/2017

Drug/Important Bio-Agent (IBA)

8rho-Associated KinasesIBA
09/2011 - 12/2003
6Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2007 - 05/2002
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2005 - 01/2003
5Angiotensin IIIBA
10/2015 - 05/2002
4AldosteroneIBA
04/2015 - 01/2003
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2014 - 03/2012
4efonidipineIBA
11/2010 - 02/2003
3dienogestFDA Link
04/2020 - 01/2020
3Pharmaceutical PreparationsIBA
01/2020 - 06/2009
3Interleukin-6 (Interleukin 6)IBA
03/2016 - 01/2010
3N,N-dimethylarginine (asymmetric dimethylarginine)IBA
03/2016 - 07/2007
3Sirtuin 1IBA
01/2016 - 04/2010
3AngiotensinsIBA
10/2015 - 07/2002
3CreatinineIBA
08/2014 - 11/2003
3CytokinesIBA
12/2012 - 05/2010
3fasudil (AT 877)IBA
09/2011 - 01/2006
3trimellitic anhydrideIBA
06/2011 - 06/2009
3candesartanIBA
06/2009 - 09/2003
3PPAR gammaIBA
05/2008 - 09/2004
3LigandsIBA
05/2008 - 09/2004
3Proteins (Proteins, Gene)FDA Link
07/2007 - 01/2005
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2005 - 05/2003
3Vasodilator Agents (Vasodilators)IBA
10/2004 - 12/2002
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 - 12/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017 - 01/2016
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2017 - 01/2011
2LipidsIBA
03/2016 - 01/2011
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2015 - 05/2008
2Angiotensin Receptor AntagonistsIBA
10/2015 - 01/2004
2ReninIBA
10/2015 - 01/2010
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
04/2015 - 01/2005
2EnzymesIBA
04/2015 - 02/2005
2Spironolactone (Aldactone)FDA LinkGeneric
04/2015 - 01/2005
2oxidized low density lipoproteinIBA
03/2015 - 01/2013
2AlbuminsIBA
08/2014 - 09/2003
2Streptozocin (Streptozotocin)FDA Link
11/2013 - 10/2008
2Nifedipine (Adalat)FDA LinkGeneric
08/2013 - 02/2007
2didecyldimethylammonium (didecyldimethylammonium chloride)IBA
07/2011 - 11/2010
2Dinitrochlorobenzene (DNCB)IBA
06/2011 - 05/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2011 - 12/2003
2OrganophosphatesIBA
03/2010 - 07/2009
2Antihypertensive Agents (Antihypertensives)IBA
06/2009 - 05/2006
2Insulin (Novolin)FDA Link
01/2006 - 12/2002
2trandolapril (Mavik)FDA LinkGeneric
01/2005 - 11/2003
2Collagen Type IV (Type IV Collagen)IBA
01/2005 - 09/2003
2CalciumIBA
01/2004 - 07/2003
2ProstaglandinsIBA
09/2002 - 05/2002
1Metformin (Glucophage)FDA LinkGeneric
01/2021
1Sodium-Glucose Transport ProteinsIBA
01/2021
1ThiazidesIBA
01/2020
1benidipineIBA
01/2020
1Rituximab (Mabthera)FDA Link
01/2017

Therapy/Procedure

12Therapeutics
01/2021 - 01/2003
5Renal Dialysis (Hemodialysis)
08/2014 - 10/2005
3Nephrectomy
03/2016 - 01/2006
2Plasma Exchange
01/2016 - 11/2013
2Aftercare (After-Treatment)
03/2015 - 11/2010
2Hemodiafiltration
11/2013 - 10/2005
1Renal Replacement Therapy (Therapies, Renal Replacement)
12/2021